Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 3,096 shares of the firm's stock in a transaction that occurred on Wednesday, March 26th. The shares were sold at an average price of $50.13, for a total value of $155,202.48. Following the completion of the sale, the director now owns 279,787 shares in the company, valued at approximately $14,025,722.31. This represents a 1.09 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Pro-Dex Stock Up 1.2 %
Pro-Dex stock opened at $49.98 on Friday. The firm has a market cap of $162.98 million, a PE ratio of 24.87 and a beta of 0.68. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.44 and a current ratio of 2.58. Pro-Dex, Inc. has a twelve month low of $16.84 and a twelve month high of $59.60. The firm's 50 day moving average price is $40.13 and its two-hundred day moving average price is $39.75.
Pro-Dex (NASDAQ:PDEX - Get Free Report) last issued its quarterly earnings data on Thursday, January 30th. The medical instruments supplier reported $0.61 earnings per share for the quarter, topping analysts' consensus estimates of $0.38 by $0.23. Pro-Dex had a net margin of 11.06% and a return on equity of 21.68%. On average, research analysts predict that Pro-Dex, Inc. will post 2 EPS for the current fiscal year.
Analyst Ratings Changes
Separately, StockNews.com cut shares of Pro-Dex from a "buy" rating to a "hold" rating in a report on Wednesday, March 12th.
Get Our Latest Analysis on Pro-Dex
Hedge Funds Weigh In On Pro-Dex
A number of hedge funds have recently made changes to their positions in PDEX. FMR LLC lifted its position in shares of Pro-Dex by 34.9% during the 3rd quarter. FMR LLC now owns 3,973 shares of the medical instruments supplier's stock worth $119,000 after buying an additional 1,028 shares during the period. Bank of New York Mellon Corp bought a new stake in shares of Pro-Dex in the 4th quarter worth about $202,000. Trexquant Investment LP acquired a new stake in shares of Pro-Dex during the 4th quarter worth about $252,000. Integrated Quantitative Investments LLC bought a new position in Pro-Dex during the 4th quarter valued at about $254,000. Finally, Arrowstreet Capital Limited Partnership acquired a new position in Pro-Dex in the fourth quarter valued at about $255,000. Institutional investors and hedge funds own 15.28% of the company's stock.
Pro-Dex Company Profile
(
Get Free Report)
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
